NasdaqGS:OPKHealthcare
Is OPKO Health (OPK) A Bargain After Its Q2 Earnings And 52 Week High?
OPKO Health (OPK) moved into focus after its Q2 2026 earnings report and guidance, which showed revenue of US$163.58 million and a sharply lower net loss compared with the prior year period.
See our latest analysis for OPKO Health.
OPKO Health shares have been volatile around the earnings release, with the 1-day share price return falling 17.27% after hitting a new 52-week high. However, the 90-day share price return of 24.09% and 1-year total shareholder return of 6.64% suggest momentum has...